DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Montemurro M, Cioffi A, Dômont J, Rutkowski P, Roth AD, von Moos R. et al.
Long-term outcome of dasatinib first-line treatment in gastrointestinal stromal tumor: A multicenter, 2-stage phase 2 trial (Swiss Group for Clinical Cancer Research 56/07).
Cancer 2018;
124: 1449-54
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.